From July 1, 2023 to September 30, 2023, the company has repurchased 3,177,900 shares, representing 5.92% for $30.83 million. With this, the company has completed the repurchase of 28,400,481 shares, representing 43.13% for $294.57 million under the buyback announced on September 19, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.38 USD | -0.95% | -0.85% | -16.55% |
12/04 | Sector Update: Health Care Stocks Lower Friday Afternoon | MT |
12/04 | Theravance Biopharma Shares Rise After BTIG Starts Coverage at Buy | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.55% | 455M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- TBPH Stock
- News Theravance Biopharma, Inc.
- Tranche Update on Theravance Biopharma, Inc.'s Equity Buyback Plan announced on September 19, 2022.